Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis

por Biondi, David M., Xiang, Jim, Etropolski, Mila, Moskovitz, Bruce
Publicado 2014

The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia

por Joshi, Kruti, Mao, Lian, Biondi, David M., Millet, Robert
Publicado 2018

Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migr...

por Pederson, Susan, Biondi, David M., Allan, Brent, Cady, Roger, Schaeffler, Barbara, Baker, Brian, Latham, John
Publicado 2021

Economic Study on the Impact of Side Effects in Patients Taking Oxycodone Controlled-Release for Noncancer Pain

por Anastassopoulos, Kathryn P., Chow, Wing, Tapia, Crisanta I., Baik, Rebecca, Ackerman, Stacey J., Biondi, David, Kim, Myoung S.
Publicado 2012

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

por Ashina, Messoud, Saper, Joel, Cady, Roger, Schaeffler, Barbara A, Biondi, David M, Hirman, Joe, Pederson, Susan, Allan, Brent, Smith, Jeff
Publicado 2020

Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2

por Lipton, Richard B., Goadsby, Peter J., Smith, Jeff, Schaeffler, Barbara A., Biondi, David M., Hirman, Joe, Pederson, Susan, Allan, Brent, Cady, Roger
Publicado 2020

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety...

por Silberstein, Stephen, Diamond, Merle, Hindiyeh, Nada A., Biondi, David M., Cady, Roger, Hirman, Joe, Allan, Brent, Pederson, Susan, Schaeffler, Barbara, Smith, Jeff
Publicado 2020